(merckgroup) -- The Merck Groups
first-quarter 2012 total revenues rose 3.2% to EUR 2,645 million compared
to EUR 2,564 million in the first quarter of 2011.
Sales for the
Group increased 3.5% to EUR2,564 million in first quarter compared to EUR2,478
million in the year-ago quarter.
This performance reflected organic
sales growth of 1.2%, a 1.7% positive benefit from changes in foreign exchange
rates and a 0.6% boost from acquisitions and divestments.
organic sales growth was entirely driven by the Merck Serono and Merck Millipore
divisions during the quarter.
The Merck Millipore life science division?s
first-quarter 2012 sales rose 7.3% year on year to EUR653m, driven by solid
results from its lab solutions and process solutions business units.
Pharmaceutical division Merck Seronos first-quarter sales increased 5.4% to
EUR1.42bn year on year, while the groups consumer health division reported sales
of EUR108m, a 7.4% decline compared to EUR116m in the first quarter of 2011.
Looking at the year as a whole, Merck expects total revenues of around
EUR10.5bn and earnings before interest, tax, depreciation and amortisation
(EBITDA) before one-time items of EUR 2.8bn-2.9bn.